Notably, genes such as SHC1 and PTK6 regulate essential signal transduction pathways, including the MAPK and PI3K cascades, which are critical for both tumour cell proliferation and resistance to programmed cell death—mechanisms that have been strongly implicated in therapeutic resistance in ccRCC [34,35]. The gene discussed is PTK6; the disease is neoplasm.